BCG vaccination induces cross-protective immunity against pathogenic microorganisms

Bacillus Calmette-Guerin (BCG) is an attenuated Mycobacterium bovis strain used as a vaccine to prevent Mycobacterium tuberculosis (M. tb) infection. Its ability to potentiate the immune response induced by other vaccines and to promote nonspecific immunomodulatory effects has been described. These effects can be triggered by epigenetic reprogramming and metabolic shifts on in-nate immune cells, a phenomenon known as trained immunity. The induction of trained immunity may contribute to explain why BCG vaccination effectively decreases disease symptoms caused by pathogens different from M. tb. This article explains the importance of BCG immunization and the possible mecha-nisms associated with the induction of trained immunity, which might be used as a strategy for rapid activation of the immune system against unrelated pathogens.

Automated summary

BCG vaccine is used to prevent tuberculosis infection and has the ability to enhance immune response to other vaccines and promote nonspecific immunomodulatory effects through epigenetic reprogramming and metabolic shifts.